Literature DB >> 11440801

Growth hormone as a neuronal rescue factor during recovery from CNS injury.

A Scheepens1, E S Sirimanne, B H Breier, R G Clark, P D Gluckman, C E Williams.   

Abstract

There is growing evidence to suggest that growth hormone plays a role in the growth and development of the CNS. Specifically, growth hormone has been implicated in promoting brain growth, myelination, neuronal arborisation, glial differentiation and cognitive function. Here we investigate if growth hormone has a role in the recovery from an unilateral hypoxic-ischaemic brain injury. Using moderate (15 min hypoxia) and severe (60 min hypoxia) models of hypoxic-ischaemia in juvenile rats and standard immunohistochemical techniques, we found intense growth hormone-like immunoreactivity present within regions of cell loss by 3 days (P<0.05). Growth hormone-like immunoreactivity was observed on injured neurones, myelinated axons, glial cells within and surrounding infarcted tissue and on the choroid plexus plus ependymal cells within the injured hemisphere. The pattern of immunoreactivity suggests that (a) growth hormone (or a growth hormone-like substance) is transported via the cerebrospinal fluid and (b) that growth hormone (or a growth hormone-like substance) is acting in a neurotrophic manner specifically targeted to injured neurones and glia. To test this hypothesis we treated a moderate hypoxic-ischaemic brain injury with 20 microg of rat growth hormone by intracerebroventricular infusion starting 2 h after injury (n=12/group). After 3 days the animals were killed and the extent of neuronal loss quantified. Growth hormone treatment reduced neuronal loss in the frontoparietal cortex (P<0.001), hippocampus (P<0.01) and dorsolateral thalamus (P<0.01) but not in the striatum. This spatial distribution of the neuroprotection conveyed by growth hormone correlates with the spatial distribution of the constitutive neural growth hormone receptor, but not with the neuroprotection offered by insulin-like growth factor-I treatment in this model. These results suggest that some of the neuroprotective effects of growth hormone are mediated directly through the growth hormone receptor and do not involve insulin-like growth factor-I induction.In summary, we have found that a growth hormone-like factor increased in the brain in the days after injury. In addition, treatment with growth hormone soon after an hypoxic-ischaemic injury reduced the extent of neuronal loss. These results further suggest that a neural growth hormone axis is activated during recovery from injury and that this may act to restrict the extent of neuronal death.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11440801     DOI: 10.1016/s0306-4522(01)00109-9

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  36 in total

1.  Sexual dimorphism of growth hormone in the hypothalamus: regulation by estradiol.

Authors:  Melisande L Addison; Emilie F Rissman
Journal:  Endocrinology       Date:  2012-02-07       Impact factor: 4.736

Review 2.  Extrapituitary growth hormone.

Authors:  S Harvey
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

3.  Exogenous growth hormone attenuates cognitive deficits induced by intermittent hypoxia in rats.

Authors:  R C Li; S Z Guo; M Raccurt; E Moudilou; G Morel; K R Brittian; D Gozal
Journal:  Neuroscience       Date:  2011-08-23       Impact factor: 3.590

4.  Selective inner retinal dysfunction in growth hormone transgenic mice.

Authors:  Brent T Martin; Edward O List; John J Kopchick; Yves Sauvé; Steve Harvey
Journal:  Growth Horm IGF Res       Date:  2011-06-25       Impact factor: 2.372

5.  Acute gonadotroph and somatotroph hormonal suppression after traumatic brain injury.

Authors:  Justin Wagner; Joshua R Dusick; David L McArthur; Pejman Cohan; Christina Wang; Ronald Swerdloff; W John Boscardin; Daniel F Kelly
Journal:  J Neurotrauma       Date:  2010-06       Impact factor: 5.269

6.  Retinal growth hormone in perinatal and adult rats.

Authors:  Steve Harvey; Marie-Laure Baudet; Esmond J Sanders
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

7.  Impairment of GH secretion in amyotrophic lateral sclerosis is not affected by riluzole treatment.

Authors:  L L Morselli; P Bongioanni; M Genovesi; R Licitra; B Rossi; L Murri; F Bogazzi; E Cecconi; E Martino; M Gasperi
Journal:  J Endocrinol Invest       Date:  2007-10       Impact factor: 4.256

8.  Insulinlike growth factor-1, insulinlike growth factor binding protein-1, and cognitive function in older men and women.

Authors:  Wael K Al-Delaimy; Denise von Muhlen; Elizabeth Barrett-Connor
Journal:  J Am Geriatr Soc       Date:  2009-06-08       Impact factor: 5.562

9.  Effects of recombinant growth hormone replacement and physical rehabilitation in recovery of gross motor function in children with cerebral palsy.

Authors:  Pedro Reimunde; Cristina Rodicio; Natalia López; Alba Alonso; Pablo Devesa; Jesús Devesa
Journal:  Ther Clin Risk Manag       Date:  2010-11-30       Impact factor: 2.423

Review 10.  Pathophysiology of hypopituitarism in the setting of brain injury.

Authors:  Joshua R Dusick; Christina Wang; Pejman Cohan; Ronald Swerdloff; Daniel F Kelly
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.